Clinical Trial Categories
Endometrial Trials
Trial ID 21461 EDP Rockville
NCT05173987clinicaltrials.gov ID
USOR ID: 21461
Phase III
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab vs. Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting
